245 results on '"Gustot, T."'
Search Results
2. Cellulitis as the first manifestation of disseminated cryptococcosis in a patient with HCV-related cirrhosis: A case report
3. P202 CFTR modulation may help refine transplant decisions in lung-liver transplant candidates
4. Involvement of High-Mobility Group Box 1 protein in acetaminophen induced liver injury: dissection of signaling pathways and potential therapeutic targeting
5. Impact of Preservation Solution on Liver Transplantation Outcome: Comparative Analysis of HTK and IGL1
6. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF (vol 72, pg 688, 2020)
7. Inflammatory bowel disease: profile of soluble cytokine receptors in Crohn's disease
8. Deficient Host-Bacteria Interactions in Inflammatory Bowel Disease? The Toll-Like Receptor (TLR)-4 Asp200gly Polymorphism is Associated with Chrohn's Disease and Ulcerative Colitis
9. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates
10. Auteurs
11. Dysfonctions circulatoires de la cirrhose et de l'insuffisance hépatique aiguë sévère
12. Does the type of preservation fluid impact on outcomes after liver transplantation?
13. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease
14. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis
15. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
16. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases
17. B-lactams serum concentrations in critically ill cirrhotic patients: a matched-control study
18. Profile of soluble cytokine receptors in Crohn’s disease
19. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis
20. Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC).
21. Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections
22. The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
23. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
24. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study
25. B-lactams serum concentrations in critically ill cirrhotic patients: a matched-control study
26. Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
27. Evaluation of the CLIF-C ACLF score in critically ill cirrhotic patients in intensive care units in Europe and North America: a multicenter cohort study
28. Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
29. Monocytes exhibit an immune and metabolic reprogramming during acute-on-chronic-liver-failure
30. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis
31. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis
32. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
33. THU-277 - Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections
34. LBP-028 - The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
35. Microcirculatory reactivity in patients with decompensated liver cirrhosis
36. LO6 : A two-stage genome-wide association study identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
37. P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response
38. O054 TM6SF2-T and PNPLA3-G genetic variants co-modulate the risk of hepatocellular carcinoma in caucasian patients with alcoholic cirrhosis. Inter-cohort validation in 1068 patients
39. P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS
40. P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE)
41. P934 THE IMPACT OF BETA-BLOCKERS ON THE COURSE OF SEVERE ALCOHOLIC HEPATITIS
42. 120 SEVERE VITAMIN D DEFICIENCY IS ASSOCIATED WITH COMPLICATIONS OF PORTAL HYPERTENSION AND A WORSE PROGNOSIS IN ALCOHOLIC CIRRHOSIS
43. 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF).
44. 532 IMPACT OF INVASIVE ASPERGILLOSIS ON SHORT-TERM MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
45. 1373 VITAMIN D DEFICIENCY IS ASSOCIATED WITH SEVERITY AND MORTALITY, AND MAY WORSEN INFLAMMATION AND FIBROSIS, IN ALCOHOLIC LIVER DISEASE
46. 1374 HISTOPATHOLOGICAL PARAMETERS ARE ASSOCIATED WITH BOTH SEVERITY AND SURVIVAL IN ALCOHOLIC HEPATITIS
47. 1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY
48. Liver Transplantation in Cases of Portal Vein Thrombosis in the Recipient: A Case Report and Review of the Various Options
49. 504 INSULIN RESISTANCE CONFERS A HIGHER RISK OF PORTAL HYPERTENSION, CIRRHOSIS AND EARLY MORTALITY TO ALCOHOLIC LIVER DISEASE PATIENTS
50. 490 HIGHLY EXPRESSED CCL-2 IN SEVERE FORM OF ALCOHOLIC HEPATITIS: A POTENTIAL ENHANCER OF THE IL-17-NEUTROPHIL LIVER RECRUITMENT PATHWAY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.